Viewing Study NCT06902467


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2025-12-25 @ 10:35 PM
Study NCT ID: NCT06902467
Status: RECRUITING
Last Update Posted: 2025-03-30
First Post: 2025-03-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module